Get the Stockscreener App
25.18
1.41%
0.35
After Hours:
25.18
Procept Biorobotics Corp stock is traded at $25.18, with a volume of 893.39K.
It is up +1.41% in the last 24 hours and up +0.24% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$24.83
Open:
$24.99
24h Volume:
893.39K
Relative Volume:
0.54
Market Cap:
$1.43B
Revenue:
$308.05M
Net Income/Loss:
$-95.57M
P/E Ratio:
-14.64
EPS:
-1.72
Net Cash Flow:
$-58.34M
1W Performance:
+9.34%
1M Performance:
+0.24%
6M Performance:
-20.34%
1Y Performance:
-53.72%
1-Day Range:
$24.25
$25.27
1-Week Range:
$21.28
$26.13
52-Week Range:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
25.18 | 1.41B | 308.05M | -95.57M | -58.34M | -1.72 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Robert W. Baird | Neutral |
| Feb-26-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-26-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Does Stronger Aquablation Tailwinds And Reaffirmed 2026 Guidance Change The Bull Case For PROCEPT (PRCT)? - Sahm
PRCT SEC FilingsProcept Biorobotics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance Reset - Yahoo Finance
Latest PRCT NewsPROCEPT BioRobotics Corporation Announces C... - Stock Titan
Assessing PROCEPT BioRobotics (PRCT) Valuation After Mixed Q1 2026 Results And Share Price Weakness - Sahm
PROCEPT BioRobotics Corp Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch - Insider Monkey
PRCT Stock Price, Quote & Chart | PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) - ChartMill
PROCEPT BioRobotics Q1 Loss Deepens To US$0.56 EPS And Tests Bullish Revenue Narratives - simplywall.st
Procept Biorobotics Charts Growth Amid Profit Pressures - TipRanks
PROCEPT BioRobotics (PRCT) CTO reports share and option stakes - Stock Titan
PROCEPT BioRobotics (NASDAQ: PRCT) Q1 2026 revenue rises 20% - Stock Titan
PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & June - Moomoo
PROCEPT BioRobotics schedules 3 investor conference appearances - Stock Titan
10 Best Robotics Stocks to Buy Under $30 - Insider Monkey
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap UpStill a Buy? - MarketBeat
Vanguard (NASDAQ: PRCT) holds 2.82M shares, a 5% stake - Stock Titan
Procept projects $390M-$410M 2026 revenue as Hydros pricing guides $450K-$460K for rest of year - MSN
Procept BioRobotics price target raised to $35 from $28 at Piper Sandler - TipRanks
PROCEPT BioRobotics Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | PROCEPT BioRobotics(PRCT.US) Q1 2026 Earnings Conference - Moomoo
PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
PROCEPT BioRobotics Q1 Earnings Call Highlights - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) reports Q1 loss, tops revenue estimates - MSN
Procept BioRobotics reports Q1 EPS (56c), consensus (55c) - TipRanks
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations - Investing.com
12,200 U.S. procedures put PROCEPT BioRobotics' systems to work in Q1 - Stock Titan
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (PRCT) PROCEPT BioRobotics Corporation Reports Q1 Revenue $83.1M, vs. FactSet Est of $80.5M - marketscreener.com
PROCEPT BioRobotics (Nasdaq: PRCT) grows Q1 2026 revenue 20% but stays loss-making - Stock Titan
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results - The Manila Times
PROCEPT BioRobotics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Procept Biorobotics in the spotlight as Q1 earnings test turnaround - Investing.com UK
Procept Biorobotics in the spotlight as Q1 earnings test turnaround By Investing.com - Investing.com Australia
Robotics Stocks To Follow TodayApril 28th - MarketBeat
PROCEPT BioRobotics (PRCT) Price Target Decreased by 16.88% to 55.27 - MSN
PROCEPT BioRobotics (PRCT) price target decreased by 37.60% to 33.58 - MSN
59,200 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Increased to Sell at Wall Street Zen - MarketBeat
PROCEPT BioRobotics (NASDAQ: PRCT) executive discloses initial stock and option stakes - Stock Titan
Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock - The Motley Fool
Procept BioRobotics stock rating reiterated at Buy by TD Cowen - Investing.com Australia
PRCT (PROCEPT BioRobotics Corporation) posts 37.2 percent year over year revenue growth, shares fall 4.48 percent on steep EPS miss.Product Revenue - UBND thành phố Hải Phòng
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Securities Fraud Investigation Into PROCEPT BioRobotics Corporati - The National Law Review
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):